ALESSANDRO GONCALVES CAMPOLINA
Projetos de Pesquisa
Unidades Organizacionais
Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas, Faculdade de Medicina
LIM/24 - Laboratório de Oncologia Experimental, Hospital das Clínicas, Faculdade de Medicina - Líder
LIM/24 - Laboratório de Oncologia Experimental, Hospital das Clínicas, Faculdade de Medicina - Líder
19 resultados
Resultados de Busca
Agora exibindo 1 - 10 de 19
conferenceObject ECONOMIC ANALYSIS OF HEPATO CELLULAR CARCINOMA TREATMENT BY SEVERITY OF DISEASE(2017) TANI, J. A.; CAMPOLINA, A. G.; DECIMONI, T. C.; TOMITAO, M.; FERREIRA, L. A.- Integrated care pathway for rectal cancer treatment: health care resource utilization, costs, and outcomes(2017) KOBAYASHI, Silvia T.; DIZ, Maria D. P. E.; CAMPOLINA, Alessandro G.; SOAREZ, Patricia C. De; RIBEIRO JR., Ulysses; NAHAS, Sergio C.; VASCONCELOS, Karina G. M. C.; CAPARELI, Fernanda; CECCONELLO, Ivan; HOFF, Paulo M.Aim: Managed Flow C20 (MFC20) is an integrated care pathway (ICP) for rectal cancer implemented at a public teaching hospital. This study aims to quantify resource utilization and estimate direct costs and outcomes associated with the use of this ICP. Methods: We evaluated consecutive rectal cancer patients treated with neoadjuvant chemoradiotherapy (nCRT) followed by surgery, comparing the period before the ICP implementation (Pre-MFC20 group) and after (MFC20 group). We assessed times between treatment steps and quantified the resources utilized, as well as their costs. Results: There were 112 patients in the Pre-MFC20 group and 218 in the MFC20 group. The mean treatment intervals were significantly shorter in the MFC20 group-from the first medical consultation to nCRT (48.3 vs. 87.5 days; P< 0.001); and from nCRT to surgery (14.8 vs. 23.0 weeks; P< 0.001) -as was the mean total treatment time (192.0 vs. 290.2 days; P< 0.001). Oncology consultations, computed tomography, MRI, and radiotherapy sessions were utilized more frequently in the Pre-MFC20 group (P< 0.001). The median per-patient cost was US$ 11 180.92 in the Pre-MFC20 group, compared with US$ 10 412.88 in the MFC20 group (P = 0.125). Daily hospital charges and consultations were the major determinants of the total cost of the treatment. There was no statistical difference in overall survival in the time periods examined. Conclusion: : Implementation of a rectal cancer ICP reduced all treatment intervals and promoted rational utilization of oncology consultations and imaging, without increment in per-patient costs or detrimental effects in overall survival.
conferenceObject Impact of Early Referral for Palliative Care in the Use of Emergency Care for Patients with Advanced Cancer(2017) ROZMAN, L. M.; CAMPOLINA, A. G.; V, R. Lopez; CHIBA, T.; SOAREZ, P. C. DeconferenceObject HEALTHCARE UTILIZATION AND SURVIVAL ASSOCIATED WITH CLINICAL CARE PATHWAY FOR RECTAL CANCER TREATMENT(2017) CAMPOLINA, A. G.; KOBAYASHI, S. T.; SOAREZ, P. C.; DIZ, M. D.- Multi-criteria decision analysis for health technology resource allocation and assessment: so far and so near?(2017) CAMPOLINA, Alessandro Goncalves; SOAREZ, Patricia Coelho De; AMARAL, Fabio Vieira do; ABE, Jair MinoroMulti-criteria decision analysis (MCDA) is an emerging tool that allows the integration of relevant factors for health technology assessment (HTA). This study aims to present a summary of the methodological characteristics of MCDA: definitions, approaches, applications, and implementation stages. A case study was conducted in the Sao Paulo State Cancer Institute (ICESP) in order to understand the perspectives of decision-makers in the process of drafting a recommendation for the incorporation of technology in the Brazilian Unified National Health System (SUS), through a report by the Brazilian National Commission for the Incorporation of Technologies in the SUS (CONITEC). Paraconsistent annotated evidential logic Et was the methodological approach adopted in the study, since it can serve as an underlying logic for constructs capable of synthesizing objective information (from the scientific literature) and subjective information (from experts' values and preferences in the area of knowledge). It also allows the incorporation of conflicting information (contradictions), as well as vague and even incomplete information in the valuation process, resulting from imperfection of the available scientific evidence. The method has the advantages of allowing explicit consideration of the criteria that influenced the decision, facilitating follow-up and visualization of process stages, allowing assessment of the contribution of each criterion separately, and in aggregate, to the decision's outcome, facilitating the discussion of diverging perspectives by different stakeholder groups, and increasing the understanding of the resulting recommendations. The use of an explicit MCDA approach should facilitate conflict mediation and optimize participation by different stakeholder groups.
conferenceObject BUDGET IMPACT ANALYSIS OF VACCINES: WHAT ARE THE METHODOLOGICAL ISSUES?(2017) SOAREZ, P. C. De; SARTORI, A. M.; LEANDRO, R. F.; SILVA, D. R.; SOAREZ, D. S.; CAMPOLINA, A. G.; NOVAES, H. M.conferenceObject RESOURCE UTILIZATION AND TREATMENT OF PATIENT WITH HEPATOCELULLAR CARCINOMA - A MICROCOSTING ANALYSIS(2017) TANI, J. A.; DECIMONI, T. C.; FERREIRA, L. A.; TOMITAO, M.; CAMPOLINA, A. G.conferenceObject HOW DOES HIGH MELD SCORE INCREASES TOTAL EXPENDITURE ON HEALTH SYSTEM? A MICRO-COSTING PROSPECTIVE COHORT STUDY(2017) TURRI, J. A.; FERREIRA, L. A.; DECIMONI, T. C.; CAMPOLINA, A. G.conferenceObject COMPARATIVE EFFECTIVENESS OF SURGICAL VERSUS NONSURGICAL THERAPY FOR LARYNGEAL AND OROPHARYNGEAL CANCER(2017) CAMPOLINA, A. G.; V, R. Lopez; LOPES, E. F.; HOFF, P. M.; CHAMMAS, R.conferenceObject Distribution of Major Malignant Neoplasms According to Sex and Diagnostic Year, Hospital Registry of Cancer, Sao Paulo State Cancer Institute, 2008-2012(2017) V, R. Lopez; CAMPOLINA, A. G.; LOPES, E. F.; HOFF, P. M.; CHAMMAS, R.